Clinical Trial Update: Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder (PDD) [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics study of risperidone in children with pervasive developmental disorders has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Pervasive Developmental Disorder

Drugs mentioned

• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Child Development Disorders, Pervasive | Phase 1 | Status: COMPLETED